Institution
Misericordia University
Recent research
- Health & MedicineOpen access
Background Anakinra is effective in recurrent pericarditis, yet optimal treatment duration and strategies for safe drug discontinuation remain uncertain. Identifying predictors of sustained remission after discontinuation is important for clinical management. Methods We retrospec...
- Health & Medicine
Occupational Therapist’s Role in Sensory Inclusive Space Design
Date presented: April 24, 2026 Primary Author and Speaker: Lori A. Charney, lcharney@misericordia.edu
- Health & Medicine
Regular physical activity offers numerous benefits to children's health and well-being and is essential for reducing cardiovascular risk in children with cardiovascular disease. Despite increasing evidence supporting its benefits, many young patients remain insufficiently active...
- BiologyOpen access
Blood cultures (BCs) remain essential for diagnosing bloodstream infections, but their yield depends largely on pre-analytical phase quality. We evaluated the impact of an intervention guided by a digital platform for blood culture key performance indicators (KPIs) automated extr...
- Health & MedicineOpen access
Subnational Heterogeneity in RSV Seasonality in Tropical Colombia, 2022–2024
Abstract Background RSV transmission in tropical settings is often assumed to occur year-round, and preventive strategies are frequently recommended accordingly. However, sub-national variation in epidemic timing remains incompletely characterized. Granular local surveillance dat...
- Health & MedicineOpen access
BACKGROUND: Oral anticoagulants (OACs), including vitamin K antagonists and direct OACs, reduce stroke risk in atrial fibrillation (AF), yet breakthrough ischemic stroke still occurs in 1-2% of patients annually despite adequate therapy. The mechanisms underlying these events rem...
- Health & Medicine
BACKGROUND: Navigating the more than 550 inborn errors of immunity (IEI) requires efficient diagnostic reasoning. Information theory suggests questions should be prioritized by their capacity to reduce diagnostic uncertainty (entropy); yet whether experts or large language models...
- BiologyOpen access
New beta-lactam/beta-lactamase inhibitor combinations (BL/BLICs) are licensed for Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae (KPC-Kp) infections. However, data regarding their efficacy against bacterial biofilms and the potential of synergistic comb...